Evidence map›Paper›PMID 27473539›Full record

ArticleJournal of clinical immunology2016

Fatal Lymphoproliferative Disease in Two Siblings Lacking Functional FAAP24.

Svenja Daschkey, Kirsten Bienemann, Volker Schuster, Hans Wolfgang Kreth, René Martin Linka, Andrea Hönscheid, Gerhard Fritz, Christian Johannes, Bernhard Fleckenstein, Bettina Kempkes and 3 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Pooled it
  2. Focal Point of Fanconi Anemia Signaling.International journal of molecular sciences · 2021
    Review
  3. Review
  4. Article
  5. Review
  6. Multifaceted Fanconi Anemia Signaling.Trends in genetics : TIG · 2018
    Review
  7. Article
  8. FANCD2 and DNA Damage.International journal of molecular sciences · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Svenja DaschkeyPediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Moorenstrasse 5, 40225, Düsseldorf, Germany.
Kirsten BienemannPediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Moorenstrasse 5, 40225, Düsseldorf, Germany. kirsten.bienemann@med.uni-duesseldorf.de.ORCID 0000-0002-1450-1928
Volker SchusterHospital for Children and Adolescents, University Leipzig, Leipzig, Germany.
Hans Wolfgang KrethChildren's Hospital, University of Würzburg, Würzburg, Germany.
René Martin LinkaPediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Moorenstrasse 5, 40225, Düsseldorf, Germany.
Andrea HönscheidPediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Moorenstrasse 5, 40225, Düsseldorf, Germany.
Gerhard FritzInsitute of Toxicology, Heinrich Heine University, Düsseldorf, Germany.
Christian JohannesCenter for Medical Biotechnology, Biological Faculty, University Duisburg-Essen, Essen, Germany.
Bernhard FleckensteinVirological Institute, Clinical and Molecular Virology, University Clinic Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Bettina KempkesDepartment of Gene Vectors, Helmholtz Center Munich, Munich, Germany.
Michael GombertPediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Moorenstrasse 5, 40225, Düsseldorf, Germany.
Sebastian GinzelPediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Moorenstrasse 5, 40225, Düsseldorf, Germany.
Arndt BorkhardtPediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Moorenstrasse 5, 40225, Düsseldorf, Germany.
Heinrich Heine University Düsseldorf · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEHelmholtz Zentrum München · DEUniversity Hospital Leipzig · DEUniversity of Duisburg-Essen · DEUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary defects in several genes have been shown to disturb the normal immune response to EBV and to give rise to severe EBV-induced lymphoproliferation in the recent years. Nevertheless, in many patients, the molecular basis of fatal EBV infection still remains unclear. The Fanconi anemia-associated protein 24 (FAAP24) plays a dual role in DNA repair. By association with FANCM as component of the FA core complex, it recruits the FA core complex to damaged DNA. Additionally, FAAP24 has been shown to evoke ATR-mediated checkpoint responses independently of the FA core complex. By whole exome sequencing, we identified a homozygous missense mutation in the FAAP24 gene (cC635T, pT212M) in two siblings of a consanguineous Turkish family who died from an EBV-associated lymphoproliferative disease after infection with a variant EBV strain, expressing a previously unknown EBNA2 allele.In order to analyze the functionality of the variant FAAP24 allele, we used herpes virus saimiri-transformed patient T cells to test endogenous cellular FAAP24 functions that are known to be important in DNA damage control. We saw an impaired FANCD2 monoubiquitination as well as delayed checkpoint responses, especially affecting CHK1 phosphorylation in patient samples in comparison to healthy controls. The phenotype of this FAAP24 mutation might have been further accelerated by an EBV strain that harbors an EBNA2 allele with enhanced activities compared to the prototype laboratory strain B95.8. This is the first report of an FAAP24 loss of function mutation found in human patients with EBV-associated lymphoproliferation.

Indexed as

MutationSiblingsAmino Acid SubstitutionCell CycleCodonConsanguinityDNA-Binding ProteinsDNA DamageDNA RepairExome SequencingFanconi Anemia Complementation Group D2 ProteinFanconi Anemia Complementation Group ProteinsFatal OutcomeFemaleGenotypeHomozygoteCodonDNA-Binding ProteinsFAAP24 protein, humanFanconi Anemia Complementation Group D2 ProteinFanconi Anemia Complementation Group ProteinsReceptors, Antigen, T-CellDNA repair defectsEBVEBV-associated lymphoproliferationFAAP24 deficiencyimmunodeficiency

Identifiers

PMID27473539
OpenAlexW2496690101

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.